Search Results 411-420 of 21265 for anti-TNF drugs

1. Ustekinumab-Auub (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Wezlana. Descriptions. Ustekinumab-auub injection is used ...

2. Naproxen (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

3. Rho(D) Immune Globulin (Injection Route, Intramuscular Route, Intravenous Route) Description and Brand Names - Mayo Clinic

   It belongs to a group of medicines called immunizing agents. Rho(D) immune globulin works to boost the immune system and prevent excessive bleeding.

4. Anakinra (Subcutaneous Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. COVID-19: A doctor or other trained health professional will give you this medicine ...

5. Domperidone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Aminophylline (Oral Route) Before Using - Mayo Clinic

   Adalimumab; Adenosine; Amifampridine; Bupropion ... drugs may be the best treatment for you. If both ... Certain medicines should not be used at or ...

7. Fenofibrate (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Antara; Fenoglide; Lipofen; Lofibra; Tricor; Triglide ...

8. Triamcinolone (Injection Route) Description and Brand Names - Mayo Clinic

   It is given to patients who are not able to take medicines by the mouth. This medicine is a corticosteroid (cortisone-like medicine or steroid).

9. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

10. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

    An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid ...